National Health Investors, Inc. (NYSE:NHI) will be posting its quarterly earnings results before the market opens on Monday, November 6th. Analysts expect National Health Investors to post earnings of $0.92 per share for the quarter. National Health Investors has set its FY17 guidance at $5.22-5.26 EPS.

National Health Investors (NYSE:NHI) last announced its quarterly earnings data on Wednesday, August 9th. The real estate investment trust reported $0.93 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.29 by ($0.36). National Health Investors had a return on equity of 12.56% and a net margin of 59.24%. The firm had revenue of $69.84 million during the quarter, compared to analysts’ expectations of $67.68 million. During the same quarter in the previous year, the business earned $1.22 earnings per share. The company’s revenue for the quarter was up 14.1% compared to the same quarter last year. On average, analysts expect National Health Investors to post $5.26 EPS for the current fiscal year and $5.45 EPS for the next fiscal year.

Shares of National Health Investors, Inc. (NHI) traded down 0.24% on Monday, hitting $76.07. The stock had a trading volume of 6,966 shares. National Health Investors, Inc. has a 52-week low of $66.31 and a 52-week high of $81.21. The firm has a market cap of $3.12 billion, a PE ratio of 19.54 and a beta of 0.56. The firm’s 50-day moving average price is $77.98 and its 200 day moving average price is $77.13.

The company also recently announced a quarterly dividend, which will be paid on Friday, November 10th. Investors of record on Friday, September 29th will be given a $0.95 dividend. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $3.80 dividend on an annualized basis and a dividend yield of 4.98%. National Health Investors’s dividend payout ratio (DPR) is presently 97.69%.

A number of brokerages recently issued reports on NHI. BidaskClub cut National Health Investors from a “hold” rating to a “sell” rating in a research report on Wednesday, August 9th. Zacks Investment Research raised National Health Investors from a “hold” rating to a “buy” rating and set a $90.00 target price for the company in a research report on Tuesday, September 5th. BMO Capital Markets reissued a “hold” rating and issued a $80.00 target price on shares of National Health Investors in a research report on Wednesday, October 18th. Finally, Stifel Nicolaus reissued a “buy” rating and issued a $82.00 target price on shares of National Health Investors in a research report on Wednesday, October 4th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and two have assigned a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $80.14.

In other National Health Investors news, insider Kevin Carlton Pascoe sold 2,000 shares of the stock in a transaction that occurred on Thursday, August 24th. The stock was sold at an average price of $79.80, for a total transaction of $159,600.00. Following the completion of the sale, the insider now directly owns 21,228 shares of the company’s stock, valued at approximately $1,693,994.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 5.19% of the stock is currently owned by company insiders.

ILLEGAL ACTIVITY WARNING: This piece of content was published by American Banking News and is the sole property of of American Banking News. If you are accessing this piece of content on another site, it was illegally copied and reposted in violation of US & international copyright & trademark laws. The correct version of this piece of content can be viewed at

National Health Investors Company Profile

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Earnings History for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with's FREE daily email newsletter.